Skip to main content

Table 5 Overall and progression free survival.

From: Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review study

 

Total

OS

 

   Median

> 20 months

   6 month

89.5%

   12 month

83.4%

PFS

 

Median

(months, 95% CI)

12.1

(8.4-15.8)

   6 month

80.3%

   12 month

51.8%